Ocular Therapeutix OCUL Derivative Gain Loss On Derivative And Other Net
Derivative Gain Loss On Derivative And Other Net at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept ocul:DerivativeGainLossOnDerivativeAndOtherNet.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's derivative gain loss on derivative and other net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's derivative gain loss on derivative and other net?
- Ocular Therapeutix (OCUL) reported derivative gain loss on derivative and other net of $1.46M in Q1 2026.
- How has Ocular Therapeutix's derivative gain loss on derivative and other net changed year-over-year?
- Ocular Therapeutix's derivative gain loss on derivative and other net increased by 248.8% year-over-year, from -$978K to $1.46M.
- What does derivative gain loss on derivative and other net mean?
- This metric represents the net non-cash impact of changes in the fair value of derivative instruments and other miscellaneous financial items. It reflects gains or losses that do not involve immediate cash outflows or inflows but are recognized in the income statement. Investors monitor this to isolate operational performance from volatility driven by financial instrument revaluations.